Phodopus roborovskii

1. Nirmatrelvir + ritonavir improves survival in P. roborovskii.

   “Nirmatrelvir + ritonavir fully suppressed transient respiratory distress and mediated complete survival of aged animals.”

   AnimalsSARS-CoV-2 infectionlung

   SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters

   Journal of virology·11 Aug 2025

2. Nirmatrelvir + ritonavir prevents respiratory sequelae in P. roborovskii.

   “Treatment of acute disease with approved antivirals, paxlovid-like nirmatrelvir + ritonavir or molnupiravir, prevented long-term respiratory sequelae in aged animals.”

   Animalsacute SARS-CoV-2 infectionlung

   SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters

   Journal of virology·11 Aug 2025

More on Nirmatrelvir + ritonavir

1. Molnupiravir prevents respiratory sequelae in P. roborovskii.

   “Treatment of acute disease with approved antivirals, paxlovid-like nirmatrelvir + ritonavir or molnupiravir, prevented long-term respiratory sequelae in aged animals.”

   Animalsacute SARS-CoV-2 infectionlung

   SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters

   Journal of virology·11 Aug 2025

More on Molnupiravir